In vitro Study of Nucleostemin as a Potential Therapeutic Target in Human Breast Carcinoma SKBR-3 Cells |
Guo, Yu
(Bioscience Department, Department of laboratory medicine, Bengbu Medical College)
Liao, Ya-Ping (Bioscience Department, Department of laboratory medicine, Bengbu Medical College) Zhang, Ding (Bioscience Department, Department of laboratory medicine, Bengbu Medical College) Xu, Li-Sha (Bioscience Department, Department of laboratory medicine, Bengbu Medical College) Li, Na (Bioscience Department, Department of laboratory medicine, Bengbu Medical College) Guan, Wei-Jun (Institute of Animal Science, Chinese Academy of Agricultural Science) Liu, Chang-Qing (Bioscience Department, Department of laboratory medicine, Bengbu Medical College) |
1 | Tsai RY (2009). Nucleolar modulation of TRF1: a dynamic way to regulate telomere and cell cycle by nucleostemin and GNL3L. Cell Cycle, 8, 2912-6. |
2 | Zhong LR, Chen X, and Wei KM (2013). Radix tetrastigma hemsleyani flavone induces apoptosis in human lung carcinoma a549 cells by modulating the MAPK pathway. Asian Pac J Cancer Prev, 14, 5983-7. 과학기술학회마을 DOI ScienceOn |
3 | Zhu Q, Meng L, Hsu JK, et al (2009). GNL3L stabilizes the TRF1 complex and promotes mitotic transition. J Cell Biol, 185, 827-39. DOI ScienceOn |
4 | Zhu Q, Yasumoto H, and Tsai RY (2006). Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol, 26, 9279-90. DOI ScienceOn |
5 | Tamase A, Muraguchi T, Naka K, et al (2009). Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci U S A, 106, 17163-8. DOI ScienceOn |
6 | Tsai RY, and McKay RD (2002). A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev, 16, 2991-3003. DOI ScienceOn |
7 | Meng L, Lin T, and Tsai RY (2008). Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci, 121, 4037-46. DOI ScienceOn |
8 | Kafienah W, Mistry S, Williams C, and Hollander AP (2006). Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells, 24, 1113-20. DOI ScienceOn |
9 | Kano M, Seki N, Kikkawa N, et al (2010). miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer, 127, 2804-14. DOI ScienceOn |
10 | Ma J, Zhang Q, Chen S, et al (2013). Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species. PLoS One, 8, e69485. DOI ScienceOn |
11 | Nomura J, Maruyama M, Katano M, et al (2009). Differential requirement for nucleostemin in embryonic stem cell and neural stem cell viability. Stem Cells, 27, 1066-76. DOI ScienceOn |
12 | Romanova L, Kellner S, Katoku-Kikyo N, and Kikyo N (2009). Novel role of nucleostemin in the maintenance of nucleolar architecture and integrity of small nucleolar ribonucleoproteins and the telomerase complex. J Biol Chem, 284, 26685-94. DOI ScienceOn |
13 | Fan Y, Liu Z, Zhao S, et al (2006). Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Br J Cancer, 94, 1658-62. |
14 | Sakamoto Y, Terashita N, Muraguchi T, et al (2013). Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis. Biosci Biotechnol Biochem, 77, 1799-803. DOI ScienceOn |
15 | Schon O, Friedler A, Bycroft M, et al (2002). Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol, 323, 491-501. DOI ScienceOn |
16 | Gu Y, Li H, Miki J, et al (2006). Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Exp Cell Res, 312, 831-43. DOI ScienceOn |
17 | Gao HX, Gao XF, Wang GQ, et al (2012). In vitro study of Nucleostemin gene as a potential therapeutic target for human lung carcinoma. Biomed Environ Sci, 25, 91-7. |
18 | Gil-Ranedo J, Mendiburu-Elicabe M, Garcia-Villanueva M, et al (2011). An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells. PLoS One, 6, e28753. DOI |
19 | Jafarnejad SM, Mowla SJ, and Matin MM (2008). Knockingdown the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner. Cell Prolif, 41, 28-35. DOI ScienceOn |
![]() |